# David L. Paterson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-l-paterson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 103,019 |
| Field | Antibiotic Resistance in Bacteria |
| h-index | 134 |
| i10-index | 576 |
| Last Known Institution | National University of Singapore |
| OpenAlex ID | https://openalex.org/A5015076483 |
| ORCID iD | https://orcid.org/0000-0003-2079-4437 |
| Works | 943 |

## Researcher papers

- [Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis](https://scholariq.org/papers/discovery-research-and-development-of-new-antibiotics-the-who-priority-list-of/)
- [Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-cefiderocol-or-best-available-therapy-for-the-treatment/)
- [Peritoneal Dialysis-Related Infections Recommendations: 2005 Update](https://scholariq.org/papers/peritoneal-dialysis-related-infections-recommendations-2005-update/)
- [Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae](https://scholariq.org/papers/colistin-versus-ceftazidime-avibactam-in-the-treatment-of-infections-due-to/)
- [Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens](https://scholariq.org/papers/treatment-outcome-of-bacteremia-due-to-kpc-producing-klebsiella-pneumoniae/)
- [Global dissemination of a multidrug resistant <i>Escherichia coli</i> clone](https://scholariq.org/papers/global-dissemination-of-a-multidrug-resistant-i-escherichia-coli-i-clone/)
- [Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study](https://scholariq.org/papers/effect-of-appropriate-combination-therapy-on-mortality-of-patients-with/)
- [The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients](https://scholariq.org/papers/the-effects-of-hypoalbuminaemia-on-optimizing-antibacterial-dosing-in-critically/)
- [Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study](https://scholariq.org/papers/global-epidemiology-and-clinical-outcomes-of-carbapenem-resistant-pseudomonas/)
- [Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial](https://scholariq.org/papers/rezafungin-versus-caspofungin-for-treatment-of-candidaemia-and-invasive/)
- [Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis](https://scholariq.org/papers/continuous-vs-intermittent-lactam-antibiotic-infusions-in-critically-ill/)

## Researcher topics

- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)
- [Bacterial Identification and Susceptibility Testing](https://scholariq.org/topics/bacterial-identification-and-susceptibility-testing/)
- [Antimicrobial Resistance in Staphylococcus](https://scholariq.org/topics/antimicrobial-resistance-in-staphylococcus/)

## Researcher university

- [National University of Singapore](https://scholariq.org/institutions/national-university-of-singapore/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.